Trial Profile
Effect of elevated glucose level or metabolic syndrome on response to telaprevir based therapy in patients with hepatitis C (HCV)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Interferon alpha-2a; Ribavirin
- Indications Hepatitis C
- Focus Pharmacokinetics
- 20 Dec 2015 New trial record